Published in Managed Care Business Week, June 20th, 2006
Scientists writing in the Journal of Cardiothoracic and Vascular Anesthesia report, "The purpose of this study was to investigate the effect of the phosphodiesterase (PDE) type 3 inhibitor milrinone on the adhesion of platelets to monocytes in vitro. [The design was a] prospective study [set in a] university experimental laboratory. Participants [were] ten healthy volunteers."
N.A. Horn and colleagues at Aachen University wrote, "Whole blood was incubated with 1, 10, or 100 mcmol/L of milrinone. After stimulation with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.